HIV Does Not Impact Survival After Liver Transplant
Last Updated:
February 03, 2011.
HIV status does not impair the likelihood of survival after liver transplant for liver cancer, according to a study published in the February issue of Hepatology.
THURSDAY, Feb. 3 (HealthDay News) -- HIV status does not impair the likelihood of survival after liver transplant for liver cancer, according to a study published in the February issue of Hepatology.
Eric Vibert, M.D., of the Hôpital Paul Brousse in Villejuif, France, and colleagues analyzed data from 21 HIV-infected and 65 HIV-negative patients with hepatocellular carcinoma who were awaiting liver transplant between 2003 and 2008. The impact of HIV infection on overall survival and recurrence-free survival after transplant was assessed.
The researchers found a higher drop-out rate among HIV-positive versus HIV-negative wait-listed patients (23 versus 10 percent; P = 0.08). HIV-positive patients had significantly higher average alpha-fetoprotein levels at the time of listing than did those who underwent transplant (16 µg/L versus 13 µg/L; P = 0.04). Among patients who underwent transplant, HIV status did not emerge as a prognostic factor for overall survival or recurrence-free survival.
"If HIV-positive patients are selected for liver transplant on the basis of strict criteria and are kept under close surveillance until surgery, there are currently no objective arguments to contradict liver transplant in this young patient population," the authors write.
AbstractFull Text (subscription or payment may be required)
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment